CLOV (Clover Health Investments) Altman Z-Score: 3.15 (As of Jun. 24, 2026)


CLOV Clover Health Investments Corp CLOV
81 GF Score
Price $5.21
GF Value $3.95
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Clover Health Investments Altman Z-Score?

Clover Health Investments CLOV +3.17% 81 Altman Z-Score is 3.15 as of Jun. 24, 2026. GuruFocus rates CLOV with a GF Score™ of 81/100 and a GF Value™ of $3.95 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 15 Healthcare Plans companies, Clover Health Investments ranks worse than 60% on this metric.

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 3.01 is strong.

Clover Health Investments has a Altman Z-Score of 3.15, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Clover Health Investments's Altman Z-Score or its related term are showing as below:

CLOV' s Altman Z-Score Range Over the Past 10 Years
Min: -3.05   Med: -0.01   Max: 6.24
Current: 3.01

During the past 7 years, Clover Health Investments's highest Altman Z-Score was 6.24. The lowest was -3.05. And the median was -0.01.


Clover Health Investments  (NAS:CLOV) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Clover Health Investments Altman Z-Score Related Terms


Clover Health Investments Altman Z-Score Historical Data

* Premium members only.

The historical data trend for Clover Health Investments's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clover Health Investments Altman Z-Score Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z-Score
Get a 7-Day Free Trial 0.22 -2.17 -2.97 1.03 0.48

Clover Health Investments Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.77 1.20 1.84 0.48 0.10

CLOV vs PGNY, ALHC, PFHO: Altman Z-Score Comparison

For the Healthcare Plans subindustry, Clover Health Investments's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments Altman Z-Score vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Altman Z-Score falls into.


CLOV
81GF Score
Clover Health Investments Corp CLOV
Altman Z-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clover Health Investments Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Clover Health Investments's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.1597+1.4*-3.2405+3.3*-0.0816+0.6*7.6584+1.0*3.1691
=3.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Mar. 2026:
Total Assets was $698 Mil.
Total Current Assets was $448 Mil.
Total Current Liabilities was $337 Mil.
Retained Earnings was $-2,261 Mil.
Pre-Tax Income was 27.334 + -49.32 + -24.377 + -10.578 = $-57 Mil.
Interest Expense was 0 + 0 + 0 + 0 = $0 Mil.
Revenue was 749.189 + 487.707 + 496.65 + 477.62 = $2,211 Mil.
Market Cap (Today) was $2,744 Mil.
Total Liabilities was $358 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(448.021 - 336.583)/697.728
=0.1597

X2=Retained Earnings/Total Assets
=-2261.018/697.728
=-3.2405

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-56.941 - 0)/697.728
=-0.0816

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=2744.025/358.302
=7.6584

X5=Revenue/Total Assets
=2211.166/697.728
=3.1691

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Clover Health Investments has a Altman Z-Score of 3.15 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.

Frequently Asked Questions Learn more about Altman Z-Score →
What does a Altman Z-Score of 3.15 mean?
Clover Health Investments (CLOV) has a Altman Z-Score of 3.15 as of Jun. 24, 2026. The Altman Z-score measures a company's bankruptcy risk. View historical data on Clover Health Investments and its competitors. According to the industry distribution chart, Clover Health Investments ranks #9 out of 15 companies in the Healthcare Plans industry, placing it in the top 60%.
Is Clover Health Investments' Altman Z-Score too high?
Clover Health Investments' current Altman Z-Score is 3.15. The Healthcare Plans industry median Altman Z-Score is 4.02. Clover Health Investments' value of 3.15 is 21.6% below this industry median. Based on the distribution chart, Clover Health Investments ranks #9 out of 15 companies in the Healthcare Plans industry, which is below the industry midpoint. Overall, Clover Health Investments has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' Altman Z-Score compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #9 out of 15 companies for Altman Z-Score. This places Clover Health Investments in the lower half of its industry. The industry median Altman Z-Score is 4.02. Clover Health Investments' value of 3.15 is 21.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z-Score for a Healthcare Plans company?
The median Altman Z-Score among Healthcare Plans companies is 4.02, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clover Health Investments's current Altman Z-Score of 3.15 is 21.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z-Score mean?
A high Altman Z-Score can signal that a stock is expensive relative to its fundamentals. The Altman Z-score measures a company's bankruptcy risk. View historical data on Clover Health Investments and its competitors. For the Healthcare Plans industry, the median Altman Z-Score is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover Health Investments's current Altman Z-Score is 3.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (CLOV) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.95, compared to a current price of $5.21 — trading 31.9% above its estimated fair value. The current Altman Z-Score is 3.15 and 21.6% below the Healthcare Plans industry median of 4.02. Clover Health Investments' overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z-Score calculated?
Altman Z-Score is calculated from a company's financial statements. For Clover Health Investments (CLOV), the current Altman Z-Score is 3.15 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Clover Health Investments (CLOV) Overvalued in 2026?

Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued. The current stock price of $5.21 is trading 31.9% above its estimated GF Value™ of $3.95. GuruFocus considers Clover Health Investments to be Significantly Overvalued.

Key valuation signals for CLOV:

  • Altman Z-Score: 3.15
  • GF Value™: $3.95 vs. price of $5.21 (31.9% above fair value)
  • GF Score™: 81/100 with 5 warning signs
  • Industry Position: 21.6% below the Healthcare Plans median (#9 of 15)

No single metric tells the full story. See the CLOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Clover Health Investments Business Description

Other Exchanges 7QD:GermanyCLOV34:Brazil
Address 3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
81GF Score

Get the complete analysis for CLOV

Altman Z-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.21
Price
$3.95
GF Value